Evidence map›Paper›PMID 27815703›Full record

ArticleRheumatology international2017

Development of an activity disease score in patients with uveitis (UVEDAI).

Esperanza Pato, Mª Auxiliadora Martin-Martinez, Adela Castelló, Rosalía Méndez-Fernandez, Santiago Muñoz-Fernández, Miguel Cordero-Coma, Lucia Martinez-Costa, Elia Valls, Miguel Reyes, Félix Francisco and 12 more

Abstract readValidation Study
In one paragraph

Article in Rheumatology international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Grand Challenges in Ocular Inflammatory Diseases.Frontiers in ophthalmology · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Esperanza PatoRheumatology Department and Health Research Institute (IdISSC), Hospital Clínico San Carlos, C/ Profesor Martin Lagos s/n, 28040, Madrid, Spain. esperanza.pato@salud.madrid.org.
Mª Auxiliadora Martin-MartinezResearch Unit of Spanish Society of Rheumatology, Madrid, Spain.
Adela CastellóCancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain.
Rosalía Méndez-FernandezOphthalmology Department and Health Research Institute (IdISSC), Hospital Clínico San Carlos, Madrid, Spain.
Santiago Muñoz-FernándezRheumatology Department, Hospital Universitario Infanta Sofia, Universidad Europea de Madrid, San Sebastian de los Reyes, Madrid, Spain.
Miguel Cordero-ComaOphthalmolgy Department, Hospital Universitario de León, León, Spain.
Lucia Martinez-CostaOphthalmolgy Department, Hospital Universitario Doctor Peset, Valencia, Spain.
Elia VallsRheumatology Department, Hospital Universitario Doctor Peset, Valencia, Spain.
Miguel ReyesOphthalmolgy Department, Hospital de Gran Canaria Doctor Negrin, Gran Canaria, Spain.
Félix FranciscoRheumatology Department, Hospital de Gran Canaria Doctor Negrin, Gran Canaria, Spain.
Mar EstebanOphthalmology Department, Hospital Universitario Infanta Sofia, San Sebastian de los Reyes, Madrid, Spain.
Alex FonollosaOphthalmology Department, BioCruces Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain.
Fernando Sanchez-AlonsoResearch Unit of Spanish Society of Rheumatology, Madrid, Spain.
Cruz Fernández-EsparteroRheumatoloy Department, Hospital Universitario de Móstoles, Móstoles, Madrid, Spain.
Teresa Diaz-ValleOphthalmology Department, Hospital Universitario de Móstoles, Móstoles, Madrid, Spain.
José Miguel CarrascoATLANTES Research Programme, Institute for Culture and Society, University of Navarra, Pamplona, Spain.
Emma Beltran-CatalánRheumatoloy Department, Hospital General Universitario de Valencia, Valencia, Spain.
Marisa Hernández-GarfellaOphthalmology Department, Hospital General Universitario de Valencia, Valencia, Spain.
María Victoria HernándezRheumatology Department, Hospital Clínic of Barcelona, Barcelona, Spain.
Laura PelegrinOphthalmology Department, Hospital Clínic of Barcelona, Barcelona, Spain.
Ricardo BlancoRheumatology Department, Hospital Universitario de Valdecilla, Santander, Spain.
David Diaz-ValleOphthalmology Department and Health Research Institute (IdISSC), Hospital Clínico San Carlos, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To develop a disease activity index for patients with uveitis (UVEDAI) encompassing the relevant domains of disease activity considered important among experts in this field. The steps for designing UVEDAI were: (a) Defining the construct and establishing the domains through a formal judgment of experts, (b) A two-round Delphi study with a panel of 15 experts to determine the relevant items, (c) Selection of items: A logistic regression model was developed that set ocular inflammatory activity as the dependent variable. The construct "uveitis inflammatory activity" was defined as any intraocular inflammation that included external structures (cornea) in addition to uvea. Seven domains and 15 items were identified: best-corrected visual acuity, inflammation of the anterior chamber (anterior chamber cells, hypopyon, the presence of fibrin, active posterior keratic precipitates and iris nodules), intraocular pressure, inflammation of the vitreous cavity (vitreous haze, snowballs and snowbanks), central macular edema, inflammation of the posterior pole (the presence and number of choroidal/retinal lesions, vascular inflammation and papillitis), and global assessment from both (patient and physician). From all the variables studied in the multivariate model, anterior chamber cell grade, vitreous haze, central macular edema, inflammatory vessel sheathing, papillitis, choroidal/retinal lesions and patient evaluation were included in UVEDAI. UVEDAI is an index designed to assess the global ocular inflammatory activity in patients with uveitis. It might prove worthwhile to motorize the activity of this extraarticular manifestation of some rheumatic diseases.

Indexed as

AdultAgedFemaleHumansInflammationMaleMiddle AgedSeverity of Illness IndexUveitisActivity indexOcular inflammationOutcome measuresUveitis

Identifiers

PMID27815703
PMCPMC5357298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.